Clinical trials for medicines: authorisation assessment performance
Transparency data on the time taken by the MHRA to assess clinical trial applications and substantial amendments.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 11 October 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (14 mars 2022). Clinical trials for medicines: authorisation assessment performance. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o5uw





